ArticleLeukemia2024

Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction.

Anthony V Moorman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.